AI Science Tracker
EN

Endostrat: a multicenter study of AI-assisted two-level risk stratification for gastric precancerous and early neoplastic lesion screening.

Affiliation not stated in the reviewed material · 28 Aug 2026 · medicine

Discovery

Endostrat: a multicenter study of AI-assisted two-level risk stratification for gastric precancerous and early neoplastic lesion screening.

Source check: Source checked. Not independent scientific confirmation.

Finding: In a retrospective three-center cohort of 8,829 patients, the two-stage Endostrat AI system stratified gastric precancerous and early-neoplastic lesion risk. This is retrospective screening-risk validation, not prospective clinical benefit.

Technology: Endostrat is a two-stage AI system for gastric-lesion risk stratification.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Endostrat is a two-stage AI system for gastric-lesion risk stratification.
Test and result
Retrospective multicenter validation in 8,829 patients across three centers; prospective screening outcomes were not tested.
Limitation / still unknown
External replication and real-world or clinical benefit were not established by the reviewed study; author affiliation is not stated in the reviewed material.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2026.1918150/full

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.

Related catalog entries

Links use documented relationships where available, plus shared catalog context. A shared topic or model family does not establish a scientific dependency.